-- -- --
Research only, not for human consumption

Lyophilised · batch-documented · discreet packaging

>99% Purity // Janoshik Verified // ACTH Analogue // Nootropic

Semax

Synthetic Heptapeptide // ACTH(4-10) Analogue // CAS 80714-61-0

Clinically approved neuroprotective peptide. Upregulates BDNF and NGF for enhanced cognition and neural resilience.

Semax is a synthetic heptapeptide analogue of the ACTH 4-10 fragment (Pro-Gly-Pro). Approved in Russia and Ukraine for ischaemic stroke, traumatic brain injury, and optic nerve disease, it increases BDNF and NGF expression while enhancing dopaminergic and serotonergic neurotransmission. Users report improved focus, memory consolidation, and stress resilience with no sedation or dependence.

BDNF↑ Primary mechanism
Approved Clinical status (Russia)
887.02 Molecular weight
14–30 Days Cycle length

Third-party tested

Every batch independently verified by Janoshik & Freedom Diagnostics for purity and identity.

Full COA included

Certificate of Analysis confirms peptide purity, amino acid composition, and absence of contaminants.

Discreet shipping

Every order ships in plain, unmarked packaging with full tracking. No external branding or product details visible.

Research-grade

Uniform vial presentation, consistent labeling, and batch-level documentation every time.

10-vial pack
,
1
View Certificate of Analysis COA
  • Janoshik & Freedom Diagnostics verified
  • Certificate of analysis per batch
  • Direct-from-manufacturer sourcing
  • Discreet, unmarked packaging
Resources

Semax Research & Reconstitution Guides

Learn more

Semax Research Guide

Keep exploring

Research Resources

Research use only. All compounds are sold strictly for in-vitro research and educational purposes. Not approved for human use, therapeutic application, or as food or cosmetic products. By purchasing, you agree to use these products only for legitimate research purposes.

Your Order